ArticleJournal of Cancer2020

Nab-paclitaxel in combination with Bevacizumab in patients with non-squamous non-small cell lung cancer after failure of at least one prior systemic regimen.

Xuezhi Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.